Nivolumab dose selection: challenges, opportunities, and lessons learned for cancer immunotherapy

Overview of attention for article published in Journal for Immunotherapy of Cancer, November 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

So far, Altmetric has seen 1 news story.

The oncology community loves to talk about precision medicine. We don't get tired of praising ourselves for being able to "select…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.